4.110EUR-2.42%Mkt Cap: —P/E: —1d ago
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic pr…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value78.33M $
Revenue (TTM)4.18M $
Gross Profit-16.32M $
Net Income (TTM)-18.03M $
Revenue/Share0.2337 USD
Last Price4.110 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees73
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.73
EV/Revenue18.73
P/S—
P/B54.08
EPS (TTM)-3.22
EPS (Forward)—
52W Range
4.1100% of range4.270
52W High4.270 EUR
52W Low4.110 EUR
Profitability
Gross Margin0.00%
Oper. Margin-414.19%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-35.52%
Growth
Revenue Growth-84.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.10M $
CapEx (TTM)—
FCF Margin-13.57%
FCF Yield—
Net Debt-9.08M $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity597.05
Current Ratio1.19
Quick Ratio1.14
Book Value/Sh0.0760 EUR
Cash/Share0.8820 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.89M
Float16.27M
Insiders6.75%
Institutions7.92%
Technical
SMA 5010.05 (-59.1%)
SMA 2008.240 (-50.1%)
Beta0.27
S&P 52W Chg18.16%
Avg Vol (30d)31
Avg Vol (10d)1.46K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—